Herpes, a type of infectious illness that usually ruins the life of patients. Herpes simplex virus is the cause of herpes. There are two types of herpes: herpes simplex virus 1 and herpes simplex virus 2. Herpes simplex virus 1 cause’s oral herpes and herpes simplex virus 2 causes genital herpes. Both types of herpes are so contagious and can be easily spreads by having sexual activities, using infected stuffs like utensils, toothbrush, towels and oral form of sexual performance. Herpes simplex virus is categorized as chronic disease hence there is no cure for herpes yet. There are several medicines are available that can only decrease the symptoms of herpes. As far as the question of herpes vaccine the reality is that there is no vaccine has developed yet to cure herpes simplex virus. But there is still a hope because researchers have designed a unique type of vaccine that could be the world’s first vaccine of herpes treatment. Two types of methods are being followed in order to develop herpes vaccines. These methods are preventing vaccine and therapeutic vaccine.
Preventing herpes vaccine: As the name suggests, the vaccine is totally designed to prevent herpes simplex virus. The testing of this vaccine has been successfully finished. Doctors believe that the prevent vaccine will prevent further outbreaks of herpes and this also give the protection against herpes simplex virus. The vaccine can be used for both types of herpes whether it’s oral herpes or genital herpes. Researchers claim that it prevents 7 out of 10 being infected by herpes virus. Researchers have been trying to make herpes vaccine for more than six decades but no one get success. But now there is a stronger hope that may be going to be true of herpes vaccine.
The therapeutic herpes vaccine is being tested in a patients of genital herpes. GN-003 is a t-cell enable vaccine that designed to reduce the severity of herpes symptoms. The vaccine also help stop shedding the herpes viruses in our body. This vaccine also help to control transmission of herpes virus in one person to other. Various tests concluded that this vaccine has enough ability to decrease the viral shedding as well as decrease the severity of herpes symptoms. Albert Einstein College of medicine researchers got success to delete glyco-protein from herpes cells. It’s glyco-protein which help herpes virus to enter in human cells. However the vaccine is still in the early stage of testing and still need perfection.